Tariq Musa 4

What Happened Tariq Musa, a director of Guardant Health (GH), had a derivative conversion/exercise on 2026-03-15 that resulted in 249 shares being acquired and 249 shares being disposed, both reported at $0.00 (no cash consideration). The net share change from these entries is zero.

Key Details

• Transaction date: 2026-03-15; Form 4 filed 2026-03-17 (timely filing).
• Transactions reported as code M (exercise or conversion of derivative): 249 shares acquired @ $0.00 and 249 shares disposed @ $0.00.
• Total cash paid/received per the filing: $0.
• Shares owned after the transaction: not provided in the excerpt.
• Footnote F1: The underlying award was restricted stock units granted March 6, 2023 that vest over four years (25% vested on the one‑year anniversary—March 15, 2023—then monthly vesting thereafter). Footnote F2: Not applicable for RSUs.

Context This appears to be a routine conversion/settlement of restricted stock units as they vest (a common non‑market transaction for insiders). Because the acquired and disposed amounts are equal and reported at $0, there was no net cash purchase or sale reported in this filing. As always, such administrative vested‑RSU transactions are different from open‑market purchases or sales and should be interpreted accordingly.